ClinicalTrials.Veeva

Menu
T

The Royal Marsden Hospital | Sutton - GI Lymphoma Research Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Afatinib
Docetaxel
BIBW 2992
Oxaliplatin
Trastuzumab
Palbociclib
Bevacizumab
GDC-0068
Doxorubicin
Estrogen

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 44 total trials

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer (STAMPEDE2)

STAMPEDE2 is a clinical trial comparing three new treatments with standard of care in people with prostate cancer that has spread to other parts of t...

Enrolling
Prostate Cancer Metastatic
Drug: Androgen Deprivation Therapy (ADT)
Drug: Prednisolone

This is a Phase 1a/1b, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, immune response, and pha...

Active, not recruiting
Bladder Cancer
Melanoma
Drug: Autogene cevumeran
Drug: Atezolizumab

This study will evaluate the safety, pharmacokinetic (PK), pharmacodynamic (PD) activity, and preliminary anti-tumor activity of GDC-9545 as a single...

Active, not recruiting
Breast Cancer
Drug: Palbociclib
Drug: LHRH Agonist

This study is researching an investigational drug, odronextamab, in adult patients B-cell non-Hodgkin's lymphoma (B-NHL).The main purpose of this stu...

Enrolling
B-cell Non-Hodgkin Lymphoma (B-NHL)
Drug: Odronextamab

This is a global, multicenter, randomized, open-label study, with an adaptive design. The main objective of the study is to measure the efficacy and...

Enrolling
Metastatic Urothelial Cancer
Drug: Pembrolizumab
Drug: BT8009

PERSEUS1 is an open-label, single arm, phase II trial evaluating the efficacy of Pembrolizumab in metastatic castration resistant prostate cancer (mC...

Enrolling
Castration-resistant Prostate Cancer
Drug: Pembrolizumab

Trial sponsors

Boehringer Ingelheim logo
Genentech logo
Roche logo
Daiichi Sankyo logo
I
R
A
B
C
Genmab logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems